Science Blog of Dr. Yuan分享 http://blog.sciencenet.cn/u/albumns This blog is mainly on Molecular molecular modelling and simulations

博文

按标题搜索
First GPCR-directed antibody passes approval milestone
2018-7-8 02:15
Nature Reviews Drug Discovery | Published online 28 Jun 2018; doi:10.1038/nrd.2018.103 https://www.nature.com/articles/nrd.2018.103 Amgen’s erenumab recently secured FDA approval as the first G protein-coupled receptor-targeted antibody. More of these biologics are on the way, de ...
个人分类: 好文转载|2725 次阅读|没有评论
The first GPCR-Gi complex structure resolved
2018-6-15 01:02
Cryo-EM structure of human rhodopsin bound to an inhibitory G protein Nature (2018) Published:13 June 2018 Abstract G-protein-coupled receptors comprise the largest family of mammalian transmembrane receptors. They mediate numerous cellular pathways by coupling with d ...
个人分类: 好文转载|3086 次阅读|没有评论
圣诞与新年快乐
2017-12-14 00:45
个人分类: 好文转载|2246 次阅读|没有评论
a postdoc position
2016-6-19 16:16
About the Agency for Science, Technology and Research (A*STAR) The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovati ...
个人分类: 好文转载|2796 次阅读|没有评论
Crystal structures of adiponectin receptors released
热度 1 2015-4-17 21:12
Nature 520, 312–316 (16 April 2015) doi:10.1038/nature14301 Full text Abstract Adiponectin stimulation of its receptors, AdipoR1 and AdipoR2, increases the activities of 5′ AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR), respectively, thereby c ...
个人分类: 好文转载|2579 次阅读|2 个评论 热度 1
2014 FDA drug approvals
2015-2-9 18:32
From Nature Reviews Drug Discovery 14, 77–81(2015) doi:10.1038/nrd4545 Drug (brand name) Sponsor Properties Indications Review types Dapagliflozin (Farxiga) AstraZeneca SGLT2 inhibitor Type 2 diabetes S Tasimelteon (Hetlioz) Vanda Melatonin-receptor agonist ...
个人分类: 好文转载|4788 次阅读|没有评论
BioVersys works to bring antinbiotic resistance to an end
2014-12-18 23:43
From http://www.venturekick.ch 9 December 2014 - In May this year, BioVersys started a project in collaboration with Lille University and GlaxoSmithKline to develop a preclinical candidate for the treatment of tuberculosis, a disease that alone kills more than 1.5 million people each ...
个人分类: 好文转载|2607 次阅读|没有评论

本页有 3 篇博文因作者的隐私设置或未通过审核而隐藏

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-4-26 13:49

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部